Description

Regulatory landscape for probiotic and herbal product combinations across different jurisdictions. Classification, approval pathways, and labeling requirements for functional foods and supplements are compared.

Figure 29

Diagram

Source Paper

Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insights into the Synergy of Probiotic-Fermented Herbal Bioactives.

International journal of molecular sciences (2025)

PMID: 40564947

DOI: 10.3390/ijms26125486

Cite This Figure

![Figure 29: Regulatory landscape for probiotic and herbal product combinations across different jurisdictions. Classification, approval pathways, and labeling requirements for functional foods and supplements are compared.]()

> Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." *International journal of molecular sciences*, 2025. PMID: [40564947](https://pubmed.ncbi.nlm.nih.gov/40564947/)

<figure>
  <img src="" alt="Regulatory landscape for probiotic and herbal product combinations across different jurisdictions. Classification, approval pathways, and labeling requirements for functional foods and supplements are compared." />
  <figcaption>Figure 29. Regulatory landscape for probiotic and herbal product combinations across different jurisdictions. Classification, approval pathways, and labeling requirements for functional foods and supplements are compared.<br>  Source: Yue Fan et al. "Gut Microbiota-Targeted Therapeutics for Metabolic Disorders: Mechanistic Insigh." <em>International journal of molecular sciences</em>, 2025. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40564947/">40564947</a></figcaption>
</figure>

Preuves associées

Berberine pour Gut Dysbiosis

Note D · 2 études